OTTAWA, ON, March 8, 2022 /PRNewswire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-derived drug discovery and development announced today that Health Canada approved the amendment of a phase I study conducted in collaboration with Dr. Jutras-Aswad and the University of Montreal Hospital Research Centre (Centre de recherche du Centre hospitalier de l’Université de Montréal, (“CRCHUM”). The …
SAN LUIS OBISPO, Calif., March 8, 2022 /PRNewswire/ — Emerald Scientific, LLC and Eighth Revolution are excited to announce their exciting new partnership. The alignment of the two scientifically-driven organizations will provide a multitude of benefits to their respective client bases, with 8th Revolution’s vast skill set helping to ignite Emerald Scientific’s expansion in serving the manufacturing, automation, and quality control space. …
TORONTO, March 08, 2022 (GLOBE NEWSWIRE) — via InvestorWire — RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company”) announced today that its subsidiary, RYAH Medtech, Inc., has received a Health Canada Medical Device License (MDL) for its proprietary Internet of Things (IoT) powered medical cannabis inhaler, proprietary cartridges and software application associated with the device. (the “RYAH Smart Medical Inhaler …
Philadelphia, PA: Osteoarthritis patients significantly decrease their daily opioid intake and experience improvements in their overall quality of life following the initiation of medical cannabis therapy, according to longitudinal data published in the journal Cureus. Investigators affiliated with Thomas Jefferson University in Philadelphia evaluated opioid consumption patterns in a cohort of 40 patients with osteoarthritis during the six-months immediately prior to and immediately …
Boulder, CO: Frequent cannabis consumers exhibit changes in psychomotor performance in the 60-minute period following their use of either marijuana flowers or concentrates, according to data published in the journal Cannabis and Cannabinoid Research. A team of investigators affiliated with the University of Colorado, the University of Washington, and Tufts University in Boston assessed the influence of cannabis on psychomotor performance as measured …
Oslo, Norway: Prescription opioid users who frequently consume the cannabis plant-derived extract medication Sativex (nabiximols) substantially reduce their opioid intake over time, according to data published in the journal Basic & Clinical Pharmacology & Technology. Sativex is an oromucosal cannabis spray containing nearly equal portions of plant-derived THC and CBD. It is available by prescription in numerous countries, but it is not FDA-approved …
TULSA, Okla., March 1, 2022 /PRNewswire/ — The cannabis industry has exploded in Oklahoma, ranking ninth in the country for the number of jobs in the cannabis industry, according to a 2021 jobs report by Leafly, a cannabis investor group. That same report shows the industry employs more than 16,000 residents, which is more cannabis workers than construction workers. To help keep pace with …
Tel Aviv, Israel: The use of medical cannabis products by older patients is associated with improvements in subjects’ quality of life and reductions in their use of concomitant medications, according to data published in the journal Frontiers in Medicine. Israeli researchers assessed the use of federally authorized medical cannabis products over a six-month period in a cohort of approximately 10,000 qualified patients. Subjects in …
Sydney, Australia: The use of oral formulations of cannabis and cannabinoids mitigate symptoms in patients with refractory pain, according to the findings of three recent human trials. In the first study, Australian researchers assessed the use of plant-derived cannabis extract oils over a three-month period in patients suffering from treatment-resistant pain. All participants experienced reductions in their pain impact scores over the …
Saskatoon, Canada: The adjunctive use of cannabis is associated with symptom mitigation and improvements in ADHD patients’ quality of life, according to case reports published in the journal Medical Cannabis and Cannabinoids. Canadian researchers documented improvements in three male ADHD patients, ages 18, 22, and 23, following the integration of cannabis into their treatment regimen. Following the use of cannabis, patients showed improvements in …